Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, connective tissue neoplasm, digestive system disorder, digestive system neoplasm, gastrointestinal stromal tumor, neoplasmRecruitingPhase 12026-02-05NCT06655246

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Kura Oncology, Inc.11

32 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Duke University Medical CenterDurhamUnited States505
Harvard UniversityBostonUnited States1
Johns Hopkins UniversityBaltimoreUnited States150
Massachusetts General HospitalBostonUnited States1015
Mayo Clinic Cancer CenterPhoenixUnited States6
Mayo Clinic Cancer CenterRochesterUnited States16
Mayo Clinic Cancer CenterJacksonvilleUnited States9
Medical College of WisconsinMilwaukeeUnited States483
Memorial Sloan-Kettering Cancer CenterNew YorkUnited States63
Northwestern UniversityChicagoUnited States727
Ohio State UniversityColumbusUnited States169
Oregon Health & Science UniversityPortlandUnited States261
Sarah Cannon Research InstituteNashvilleUnited States119
Sarah Cannon Research InstituteDenverUnited States1
Sarah Cannon Research InstituteDallasUnited States3
Stanford Cancer InstitutePalo AltoUnited States21
Temple University Health SystemPhiladelphiaUnited States1
Thomas Jefferson UniversityPhiladelphiaUnited States165
UCLA Santa Monica Medical CenterSanta MonicaUnited States2
University of Alabama at BirminghamBirminghamUnited States193
University of California, IrvineOrangeUnited States29
University of California, San DiegoLa JollaUnited States38
University of Colorado Cancer CenterAuroraUnited States63
University of IowaIowa CityUnited States284
University of MiamiMiamiUnited States327